In silico Analysis of 3D-QSAR and Molecular Docking for Bcl-2 Inhibitors to Potential Anticancer Drug Development.
Ramachandran, M; Nambikkairaj, Balwin; Kumaran, K; De, Arun Kumar; Kumar, G Ramesh.
Artículo en Inglés | IMSEAR | ID: sea-151897
Documentos relacionados
3D-QSAR assisted identification of selective CYP1B1 inhibitors: an effective bioisosteric replacement/molecular docking/electrostatic complementarity analysis.
Design and development of novel potential inhibitors of the human USP21 enzyme using a pharmacophore-based virtual screening technique.
In the quest for histone deacetylase inhibitors: current trends in the application of multilayered computational methods.
Inverse QSAR: Reversing Descriptor-Driven Prediction Pipeline Using Attention-Based Conditional Variational Autoencoder.
Outliers in SAR and QSAR: 4. effects of allosteric protein-ligand interactions on the classical quantitative structure-activity relationships.
Pharmacophore Modeling of Targets Infested with Activity Cliffs via Molecular Dynamics Simulation Coupled with QSAR and Comparison with other Pharmacophore Generation Methods: KDR as Case Study.
QSAR studies on benzothiophene derivatives as Plasmodium falciparum N-myristoyltransferase inhibitors: Molecular insights into affinity and selectivity.
Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists.
dMXP: A <i>De Novo</i> Small-Molecule 3D Structure Predictor with Graph Attention Networks.
Leveraging Cell Painting Images to Expand the Applicability Domain and Actively Improve Deep Learning Quantitative Structure-Activity Relationship Models.